Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171586004> ?p ?o ?g. }
- W2171586004 endingPage "664.e8" @default.
- W2171586004 startingPage "655" @default.
- W2171586004 abstract "Our objective was to analyze periprocedural and 1-year outcomes of peripheral endovascular intervention (PVI) for critical limb ischemia (CLI).We reviewed 1244 patients undergoing 1414 PVIs for CLI (rest pain, 29%; tissue loss, 71%) within the Vascular Study Group of New England (VSGNE) from January 2010 to December 2011. Overall survival (OS), amputation-free survival (AFS), and freedom from major amputation at 1 year were analyzed using the Kaplan-Meier method. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).The number of arteries treated during each procedure were 1 (49%), 2 (35%), 3 (12%), and ≥4 (5%). Target arterial segments and TransAtlantic Inter-Society Consensus classifications were aortoiliac, 27% (A, 48%; B, 28%; C, 12%; and D, 12%); femoral-popliteal, 48% (A, 29%; B, 34%; C, 20%; and D, 17%); and infrapopliteal, 25% (A, 17%; B, 14%; C, 25%; D, 44%). Technical success was 92%. Complications included access site hematoma (5.0%), occlusion (0.3%), and distal embolization (2.4%). Mortality and major amputation rates were 2.8% and 2.2% at 30 days, respectively. Overall percutaneous or open reintervention rate was 8.0% during the first year. At 1-year, OS, AFS, and freedom from major amputation were 87%, 87%, and 94% for patients with rest pain and 80%, 71%, and 81% for patients with tissue loss. Independent predictors of reduced 1-year OS (C index = .74) included dialysis (HR, 3.8; 95% CI, 2.8-5.1; P < .01), emergency procedure (HR, 2.5; 95% CI, 1.0-6.2; P = .05), age >80 years (HR, 2.2; 95% CI, 1.7-2.8; P < .01), not living at home preoperatively (HR, 2.0; 95% CI, 1.4-2.8; P < .01), creatinine >1.8 mg/dL (HR, 1.9; 95% CI, 1.3-2.8; P < .01), congestive heart failure (HR, 1.7; 95% CI, 1.3-2.2; P < .01), and chronic β-blocker use (HR, 1.4; 95% CI, 1.0-1.9; P = .03), whereas independent preoperative ambulation (HR, 0.7; 95% CI, 0.6-0.9; P = .014) was protective. Independent predictors of major amputation (C index = .69) at 1 year included dialysis (HR, 2.7; 95% CI, 1.6-4.5; P < .01), tissue loss (HR, 2.0; 95% CI, 1.1-3.7; P = .02), prior major contralateral amputation (HR, 2.0; 95% CI, 1.1-3.5; P = .02), non-Caucasian race (HR, 1.7; 95% CI, 1.0-2.9; P = .045), and male gender (HR, 1.6; 95% CI, 1.1-2.6; P = .03), whereas smoking (HR, .60; 95% CI, 0.4-1.0; P = .042) was protective.Survival and major amputation after PVI for CLI are associated with different patient characteristics. Dialysis dependence is a common predictor that portends especially poor outcomes. These data may facilitate efforts to improve patient selection and, after further validation, enable risk-adjusted outcome reporting for CLI patients undergoing PVI." @default.
- W2171586004 created "2016-06-24" @default.
- W2171586004 creator A5000492757 @default.
- W2171586004 creator A5015016192 @default.
- W2171586004 creator A5032316277 @default.
- W2171586004 creator A5044493690 @default.
- W2171586004 creator A5065001569 @default.
- W2171586004 creator A5076237470 @default.
- W2171586004 creator A5090442172 @default.
- W2171586004 date "2015-09-01" @default.
- W2171586004 modified "2023-10-14" @default.
- W2171586004 title "Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia" @default.
- W2171586004 cites W1973230733 @default.
- W2171586004 cites W1984684769 @default.
- W2171586004 cites W1990000875 @default.
- W2171586004 cites W1991476456 @default.
- W2171586004 cites W2031589276 @default.
- W2171586004 cites W2032435891 @default.
- W2171586004 cites W2044381705 @default.
- W2171586004 cites W2052912940 @default.
- W2171586004 cites W2057398300 @default.
- W2171586004 cites W2072085645 @default.
- W2171586004 cites W2088883087 @default.
- W2171586004 cites W2092082358 @default.
- W2171586004 cites W2122523807 @default.
- W2171586004 cites W2128616793 @default.
- W2171586004 cites W2129226196 @default.
- W2171586004 cites W2144985796 @default.
- W2171586004 cites W2145600607 @default.
- W2171586004 cites W2148325862 @default.
- W2171586004 cites W2148895634 @default.
- W2171586004 cites W2160810667 @default.
- W2171586004 cites W2185467918 @default.
- W2171586004 doi "https://doi.org/10.1016/j.jvs.2015.04.391" @default.
- W2171586004 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5315445" @default.
- W2171586004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26215708" @default.
- W2171586004 hasPublicationYear "2015" @default.
- W2171586004 type Work @default.
- W2171586004 sameAs 2171586004 @default.
- W2171586004 citedByCount "36" @default.
- W2171586004 countsByYear W21715860042016 @default.
- W2171586004 countsByYear W21715860042017 @default.
- W2171586004 countsByYear W21715860042018 @default.
- W2171586004 countsByYear W21715860042019 @default.
- W2171586004 countsByYear W21715860042020 @default.
- W2171586004 countsByYear W21715860042021 @default.
- W2171586004 countsByYear W21715860042022 @default.
- W2171586004 countsByYear W21715860042023 @default.
- W2171586004 crossrefType "journal-article" @default.
- W2171586004 hasAuthorship W2171586004A5000492757 @default.
- W2171586004 hasAuthorship W2171586004A5015016192 @default.
- W2171586004 hasAuthorship W2171586004A5032316277 @default.
- W2171586004 hasAuthorship W2171586004A5044493690 @default.
- W2171586004 hasAuthorship W2171586004A5065001569 @default.
- W2171586004 hasAuthorship W2171586004A5076237470 @default.
- W2171586004 hasAuthorship W2171586004A5090442172 @default.
- W2171586004 hasBestOaLocation W21715860041 @default.
- W2171586004 hasConcept C126322002 @default.
- W2171586004 hasConcept C141071460 @default.
- W2171586004 hasConcept C207103383 @default.
- W2171586004 hasConcept C2776204877 @default.
- W2171586004 hasConcept C2777303625 @default.
- W2171586004 hasConcept C2777466421 @default.
- W2171586004 hasConcept C2779978075 @default.
- W2171586004 hasConcept C2780813298 @default.
- W2171586004 hasConcept C2781099653 @default.
- W2171586004 hasConcept C3018348675 @default.
- W2171586004 hasConcept C44249647 @default.
- W2171586004 hasConcept C50382708 @default.
- W2171586004 hasConcept C541997718 @default.
- W2171586004 hasConcept C71924100 @default.
- W2171586004 hasConceptScore W2171586004C126322002 @default.
- W2171586004 hasConceptScore W2171586004C141071460 @default.
- W2171586004 hasConceptScore W2171586004C207103383 @default.
- W2171586004 hasConceptScore W2171586004C2776204877 @default.
- W2171586004 hasConceptScore W2171586004C2777303625 @default.
- W2171586004 hasConceptScore W2171586004C2777466421 @default.
- W2171586004 hasConceptScore W2171586004C2779978075 @default.
- W2171586004 hasConceptScore W2171586004C2780813298 @default.
- W2171586004 hasConceptScore W2171586004C2781099653 @default.
- W2171586004 hasConceptScore W2171586004C3018348675 @default.
- W2171586004 hasConceptScore W2171586004C44249647 @default.
- W2171586004 hasConceptScore W2171586004C50382708 @default.
- W2171586004 hasConceptScore W2171586004C541997718 @default.
- W2171586004 hasConceptScore W2171586004C71924100 @default.
- W2171586004 hasIssue "3" @default.
- W2171586004 hasLocation W21715860041 @default.
- W2171586004 hasLocation W21715860042 @default.
- W2171586004 hasLocation W21715860043 @default.
- W2171586004 hasLocation W21715860044 @default.
- W2171586004 hasOpenAccess W2171586004 @default.
- W2171586004 hasPrimaryLocation W21715860041 @default.
- W2171586004 hasRelatedWork W2002989198 @default.
- W2171586004 hasRelatedWork W2012720002 @default.
- W2171586004 hasRelatedWork W2118215538 @default.
- W2171586004 hasRelatedWork W2119154902 @default.
- W2171586004 hasRelatedWork W2161795058 @default.
- W2171586004 hasRelatedWork W2462411159 @default.